TABLE 4.

Descriptive Injection-Related Characteristics Among Persons Who Inject Drugs From NHBS-Trans 2019–2020 and NHBS-PWID 2018–7 US Cities

	NHBS-Trans 2019–2020		NHBS-PWID 2018
Characteristic	n*	Col %*	n*	Col %*
Injected Methamphetamine, past 12 mo
No	23	22.1	1871	51.6
Yes	81	77.9	1756	48.4
Injected heroin, past 12 mo
No	67	64.4	365	10.1
Yes	37	35.6	3262	89.9
Drug most injected, past 12 mo
Speedball	3	2.9	219	6.1
Heroin	29	27.9	1832	50.7
Methamphetamine	70	67.3	332	9.2
Oxycontin or painkillers	2	1.9	12	0.3
Other drug(s)†	NA	NA	1220	33.7
Frequency of injection, past 12 mo
At least once a day	48	47.4	3184	87.9
More than once a week	19	18.8	258	7.1
Once a week or less	34	33.7	179	4.9
Noninjection drug use, past 12 mo
No	19	18.3	608	16.8
Yes	85	81.7	3019	83.2
Noninjection methamphetamine use, past 12 mo
No	33	31.7	1901	52.5
Yes	71	68.3	1721	47.5
Shared syringes (receptive), past 12 mo
No	64	72.7	2551	70.4
Yes	24	27.3	1074	29.6
Always sterile syringe use, past 12 mo
No	40	38.5	2288	63.1
Yes	64	61.5	1339	36.9
Accessed syringe services programs, past 12 mo
No	34	34.0	782	22.6
Yes	66	66.0	2686	77.5
Accessed drug treatment, past 12 mo
No	58	57.0	2045	56.4
Yes	46	43.0	1580	43.6
NHBS HIV test result
Negative	45	43.3	235	93.5
Positive	59	56.7	3372	6.5
Total	104	100.0	3627	100.0

^*N’s do not include missing values. Percentages may not add up to 100% because of rounding.

^†NHBS-Trans transgender women who inject did not report any other most injected drugs. Other drugs reported by NHBS-PWID persons who inject included cocaine, crack, multiple drugs, or other drugs not specified.

NA, not applicable.